Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out

Labels

March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info: https://youtu.be/811v7RLXP9M
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country
MEBO TMAU TESTING DISCONTINUED
(2012-2017)

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact info@meboresearch.org

MEBO - UBIOME study 2018

'PRESS RELEASE'

NCT03582826
ClinicalTrials.gov

MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person

NO LONGER RECRUITING

Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts

MEBO TMAU Videos

Petitions

TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect
rareconnect.org TMAU

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

Denver TMAU Test Lab survey click here
click to Read more/less

USA survey for anyone who wants to improve Denver TMAU test

begun : Dec22
end : no ending for now

A trainee genetic counselor is working at the Denver TMAU test lab. Probably as part of her training. As a project she wishes feedback on any aspect of the Denver TMAU test and process. You can fill in the survey and/or email her (email address is in survey). It's meant for USA people, but perhaps others can give their view too (as we have so few opportunities).

quote from her rareconnect post

"Hello all! I wanted to make you aware of a research study being conducted to better understand the experience and needs of individuals with trimethylaminuria with a goal of being able to create improved patient and healthcare provider education materials. Any participation is completely voluntary and all responses remain confidential. Feel free to use the contact information within the link with any questions or share the survey with others with TMAU."

see this post for more details

https://www.meboblog.com/2023/01/denver-tmau-test-survey-tbc-who-it-is.html

Wednesday, November 4, 2020

Skin bacteria in gut as biomarkers of systemic malodor & PATM


Today, Irene Gabashvili, PhD., MEBO Research Scientific Director and Principal Investigator of the MEBO Clinical Trial, "Microbial Basis of Systemic Malodor and PATM Conditions (PATM), NCT03582826(2018-2020), published a paper on the findings of this study in the JMIR Dermatology Publications.

A total of 112 individuals from 22 countries consented to participate, of which 84 fully participated in the study.
The study referenced in the article, "Cutaneous Bacteria in the Gut Microbiome as Biomarkers of Systemic Malodor and People Are Allergic to Me (PATM) Conditions: Insights From a Virtually Conducted Clinical Trial," suggests that body and/or breath odor was increased when the levels of bacteria previously associated with skin body odor were significantly elevated in the gut samples of the study. Gut samples indicated an elevated "combination of species from Anaerococcus, Corynebacterium, Campylobacter, and Propionibacterium genera..."

About half of the participants had previously tested for trimethylaminuria (TMAU), and about half of those tested were diagnosed with the disorder.
A total of 112 individuals from 22 countries consented to participate, of which 84 fully participated in the study. About half of the participants had previously tested for trimethylaminuria (TMAU), and about half of those tested were diagnosed with the disorder. “Of the 84 study volunteers, 41 (49%; 41/78, 53% of MEBO/PATM cohort) tested for the odor-producing disorder TMAU, with 13 positives for primary TMAU and 8 for secondary TMAU, a nongenetic form arising from dysbiosis in the gut bacteria.”

Dr. Gabashvili discusses her finding in her Aurametrix site, Olfactics and Olfactory Diagnostics: New Paper Reveals Insights into Bacteria that Live...: What do MEBO (metabolic body odor), PATM ("People are Allergic to ME" condition) and TMAU (trimethylaminuria) have in common...

Irene gives us the following page in her Aurametrix Blog, which shows the last 3-4 digits of MEBO participants' IDs. This way they can recognize themselves in the "vector field" of results. These 22 participants had at least one pair of "better" and "worse" MEBO/PATM symptoms. The paper has more figures with results of the remaining participants, analyzed in several different ways.

Quotes from the paper:
Conclusions: ...Our work paves the way for the development of cost-effective diagnostics of MEBO and PATM conditions based on an at-home stool test...
Another implication of this work is that individuals with a high abundance of cutaneous malodor bacteria in the gut might benefit from reducing levels of these bacteria. We note that one of the common causes of both halitosis and axillar odor is a zinc deficiency. Zinc oxide is known to decrease populations of bacteria discussed in this work when applied externally [41], attenuating self-perceived malodor. Zinc also contributes to the reduction of halitosis [42]. However, not all people with MEBO and PATM are zinc deficient, and it is important to retain certain levels of cutaneous odor-producing bacteria in the body, as they prevent some skin, ear, and respiratory infections

REFERENCE:

Gabashvili IS
Cutaneous Bacteria in the Gut Microbiome
as Biomarkers of Systemic Malodor
and People Are Allergic to Me (PATM) Conditions:
Insights From a Virtually Conducted Clinical Trial

JMIR Dermatol 2020;3(1):e10508
URL: https://derma.jmir.org/2020/1/e10508
doi:10.2196/10508
Trial Registration:ClinicalTrials.gov NCT03582826
International Registered Report Identifier
(IRRID):RR2-10.1101/2020.08.21.20179242

ACKNOWLEDGMENTS:

We are most grateful to MEBO's Scientific Director, Irene Gabashvili, PhD., Principal Investigator of this study, for offering her pro-bono professional through the years for this and all other MEBO Research clinical trials.Our profound appreciation to uBiome for the research grant they awarded MEBO for this study as well as to their representative, Melissa Agnello for processing the samples. We appreciate the professional psychological guidance that Crissan Rosalia, MEBO Mental Health Director, Health Psychologist, MSc., with articles she has written for our MEBO community around the world. These can be found in the MEBO MENTAL HEALTH BLOG.

María

María de la Torre
Founder and Executive Director

A Public Charity
www.meboresearch.org
MEBO's Blog (English)
El Blog de MEBO (español)



SUPPORT THE MEBO MISSION:
Click Amazon button at right sidebar of this blog when shopping online
for the holidays
at no extra cost to you.
MEBO gets small commission from Amazon.


get New Posts by EMAIL : Enter your email address :





A EURORDIS and NORD Member Organization

0 comments:

Post a Comment